1. Australia Diabetes Care Devices Market Outlook to 2018-
Glucose Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 85
Price: Single User License – US$2500
Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Australia Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the Australia Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Australia Diabetes Care
Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S , Sanofi , Abbott
Laboratories , Eli Lilly and Company , Becton, Dickinson and Company and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Australia Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197491-australia-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What is This Report About? 8
3 Diabetes Care Devices In Australia 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 10
3.3 Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2011 11
3.4 Diabetes Care Devices Market, Australia, Category Contribution (%), 2011 12
3.5 Diabetes Care Devices, Australia, Company Share (2010-2011) 19
4 Glucose Monitoring In Australia 21
4.1 Glucose Monitoring, Market Segmentation 21
4.2 Glucose Monitoring Market, Australia, Revenue Mix ($m), 2011 22
4.3 Glucose Monitoring Market, Australia, Segment Contribution (%), 2011 23
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 24
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 28
4.5 Glucose Monitoring Overall Volume (2004-2018) 32
4.5.1 Blood Glucose Meters, Volume (2004-2018) 35
4.6 Glucose Monitoring Average Price (2004-2018) 38
4.7 Glucose Monitoring Distribution Share (2010-2011) 39
4.8 Glucose Monitoring, Australia, Company Share (2010-2011) 40
5 Insulin Delivery In Australia 42
5.1 Insulin Delivery, Market Segmentation 42
5.2 Insulin Delivery Market, Australia, Revenue Mix ($m), 2011 43

3. 5.3 Insulin Delivery Market, Australia, Segment Contribution (%), 2011 44
5.4 Insulin Delivery Overall Revenue, (2004-2018) 45
5.4.1 Insulin Pens, Revenue (2004-2018) 49
5.4.2 Insulin Pumps, Revenue (2004-2018) 53
5.5 Insulin Delivery Overall Volume (2004-2018) 55
5.5.1 Insulin Pens, Volume (2004-2018) 59
5.5.2 Insulin Pumps, Volume (2004-2018) 63
5.6 Insulin Delivery Average Price (2004-2018) 65
5.7 Insulin Delivery Distribution Share (2010-2011) 66
5.8 Insulin Delivery, Australia, Company Share (2010-2011) 67
6 Overview of Key Companies in Australia Diabetes Care Devices Market 69
6.1 F. Hoffmann-La Roche Ltd. 69
6.1.1 Company Overview 69
6.1.2 Share in the Australia Diabetes Care Devices Market 69
6.2 Novo Nordisk A/S 70
6.2.1 Company Overview 70
6.2.2 Share in the Australia Diabetes Care Devices Market 70
6.3 Sanofi 71
6.3.1 Company Overview 71
6.3.2 Share in the Australia Diabetes Care Devices Market 71
6.4 Abbott Laboratories 72
6.4.1 Company Overview 72
6.4.2 Share in the Australia Diabetes Care Devices Market 72
6.5 Eli Lilly and Company 73
6.5.1 Company Overview 73
6.5.2 Share in the Australia Diabetes Care Devices Market 73
6.6 Becton, Dickinson and Company 74
6.6.1 Company Overview 74
6.6.2 Share in the Australia Diabetes Care Devices Market 74
6.7 Bayer HealthCare AG 75
6.7.1 Company Overview 75
6.8 Medtronic, Inc. 75
6.8.1 Company Overview 75
6.9 ARKRAY, Inc. 76
6.9.1 Company Overview 76
6.10 Animas Corporation 76
6.10.1 Company Overview 76
6.11 B. Braun Melsungen AG 76
6.11.1 Company Overview 76
7 Diabetes Care Devices Market Pipeline Products 77
8 Appendix 80
8.1 Definitions of Markets Covered in the Report 81

4. 8.1.1 Diabetes Care Devices 81
8.2 Research Methodology 83
8.3 Secondary Research 83
8.4 Primary Research 84
8.5 Models 84
8.6 Forecasts 84
8.7 Expert Panels 85
8.8 GlobalData Consulting 85
8.9 Currency Conversion 85
8.10 Contact Us 85
8.11 Disclaimer 85
1.1 List of Tables
Table 1: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 10
Table 2: Diabetes Care Devices Market, Australia, Category Contribution (%), 2011 12
Table 3: Diabetes Care Devices, Australia, Cross-Segment Analysis, 2004-2018 14
Table 4: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Table 5: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 18
Table 6: Diabetes Care Devices, Australia, Company Share by Revenue ($m), USD Constant,
2010-2011 20
Table 7: Glucose Monitoring Market, Australia, Segment Contribution (%), 2011 23
Table 8: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 25
Table 9: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 27
Table 10: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 29
Table 11: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 31
Table 12: Glucose Monitoring, Australia, Volume (Units) by Segment, Historic, 2004-2011 33
Table 13: Glucose Monitoring, Australia, Volume (Units) by Segment, Forecast, 2011-2018 34
Table 14: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011
35
Table 15: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018
37
Table 15: Glucose Monitoring, Australia, Average Price ($), Historic, 2004-2011 38
Table 16: Glucose Monitoring, Australia, Average Price ($), Forecast, 2011-2018 38
Table 17: Glucose Monitoring, Australia, Distribution Share by Revenue ($m), USD Constant,
2010-2011 39
Table 18: Glucose Monitoring, Australia, Company Share by Revenue ($m), USD Constant, 2010-

5. 2011 41
Table 19: Insulin Delivery Market, Australia, Segment Contribution (%), 2011 44
Table 20: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 46
Table 21: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 48
Table 22: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 50
Table 23: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 52
Table 24: Insulin Pumps, Australia, Revenue ($m) USD Constant, Historic, 2004-2011 53
Table 25: Insulin Pumps, Australia, Revenue ($m) USD Constant, Forecast, 2011-2018 54
Table 26: Insulin Delivery, Australia, Volume (Units) by Segment, Historic, 2004-2011 56
Table 27: Insulin Delivery, Australia, Volume (Units) by Segment, Forecast, 2011-2018 58
Table 28: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 60
Table 29: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62
Table 30: Insulin Pumps, Australia, Volume (Units), Historic, 2004-2011 63
Table 31: Insulin Pumps, Australia, Volume (Units), Forecast, 2011-2018 64
Table 32: Insulin Delivery, Australia, Average Price ($), Historic, 2004-2011 65
Table 33: Insulin Delivery, Australia, Average Price ($), Forecast, 2011-2018 65
Table 34: Insulin Delivery, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 66
Table 35: Insulin Delivery, Australia, Company Share by Revenue ($m), USD Constant, 2010-
2011 68
Table 36: Diabetes Care Devices Market Pipeline Products 77
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 9
Figure 2: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 10
Figure 3: Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2011 11
Figure 4: Diabetes Care Devices Market, Australia, Category Contribution (%), 2011 12
Figure 5: Diabetes Care Devices, Australia, Cross-Segment Analysis, 2004-2018 13
Figure 6: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 15
Figure 7: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 17
Figure 8: Diabetes Care Devices, Australia, Company Share (%)-2011 19
Figure 9: Glucose Monitoring, Market Segmentation 21
Figure 10: Glucose Monitoring Market, Australia, Revenue Mix ($m), 2011 22
Figure 11: Glucose Monitoring Market, Australia, Segment Contribution (%), 2011 23
Figure 12: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 24

6. Figure 13: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 26
Figure 14: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 28
Figure 15: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 30
Figure 16: Glucose Monitoring, Australia, Volume (Units) by Segment, Historic, 2004-2011 32
Figure 17: Glucose Monitoring, Australia, Volume (Units) by Segment, Forecast, 2011-2018 34
Figure 18: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011
35
Figure 19: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 36
Figure 19: Glucose Monitoring, Australia, Company Share (%), 2011 40
Figure 20: Insulin Delivery, Market Segmentation 42
Figure 21: Insulin Delivery Market, Australia, Revenue Mix ($m), 2011 43
Figure 22: Insulin Delivery Market, Australia, Segment Contribution (%), 2011 44
Figure 23: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 45
Figure 24: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 47
Figure 25: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 49
Figure 26: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 51
Figure 27: Insulin Pumps, Australia, Revenue ($m) USD Constant, Historic, 2004-2011 53
Figure 28: Insulin Pumps, Australia, Revenue ($m) USD Constant, Forecast, 2011-2018 54
Figure 29: Insulin Delivery, Australia, Volume (Units) by Segment, Historic, 2004-2011 55
Figure 30: Insulin Delivery, Australia, Volume (Units) by Segment, Forecast, 2011-2018 57
Figure 31: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 59
Figure 32: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 61
Figure 33: Insulin Pumps, Australia, Volume (Units), Historic, 2004-2011 63
Figure 34: Insulin Pumps, Australia, Volume (Units), Forecast, 2011-2018 64
Figure 35: Insulin Delivery, Australia, Company Share (%), 2011 67
Figure 36: F. Hoffmann-La Roche Ltd., Company Share (%),Australia Diabetes Care Devices
Market, 2011 69
Figure 37: Novo Nordisk A/S, Company Share (%),Australia Diabetes Care Devices Market, 2011
70
Figure 38: Sanofi, Company Share (%),Australia Diabetes Care Devices Market, 2011 71
Figure 39: Abbott Laboratories, Company Share (%),Australia Diabetes Care Devices Market,
2011 72
Figure 40: Eli Lilly and Company, Company Share (%),Australia Diabetes Care Devices Market,
2011 73

7. Figure 41: Becton, Dickinson and Company, Company Share (%),Australia Diabetes Care Devices
Market, 2011 74
Contact: sales@reportsandreports.com for more information.